SCHEMBL14310653

SCHEMBL14310653

Bc1cccc(-c2cnn3c(N)c(-c4cccc(Cl)c4)c(CF)nc23)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.50
▸ KMT2A Q03164 8/20 0.50
▸ NPC1 O15118 8/20 0.50
▸ RAB9A P51151 8/20 0.50
▸ FYN P06241 1/20 0.44
▸ MAPT P10636 4/20 0.43
▸ HPGD P15428 3/20 0.43
▸ GAA P10253 1/20 0.43
▸ CASP3 P42574 2/20 0.41
▸ SENP8 Q96LD8 2/20 0.41
▸ SENP7 Q9BQF6 2/20 0.41
▸ SENP6 Q9GZR1 2/20 0.41
▸ BLM P54132 1/20 0.39
▸ NCOA1 Q15788 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ DHFR P00374 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ PIM1 P11309 2/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4175269 0.88 MEN1 (0.50) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL4171927 0.84 FYN (0.67) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL13914415 0.77 GPR119 (0.38) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL4173016 0.77 LCK (0.40) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL4695093 0.75 FYN (0.68) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL13905658 0.72 MEN1 (0.61) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL4168402 0.70 KMT2A (0.58) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL4695452 0.69 FYN (0.60) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL4167662 0.69 FYN (0.59) MEN1KMT2ANPC1RAB9AFYN
SCHEMBL4179850 0.69 FYN (0.71) MEN1KMT2ANPC1RAB9AFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007103432-A9 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2008-01-10 — — WO disclosed
Send feedback